Medicine import support device, medicine import support method, and medicine import support program

The drug import support device and method address the complexities of importing unapproved drugs into Japan by streamlining the information collection and application submission process, thereby reducing the risk of delays or rejections and ensuring smoother import operations.

JP2025062725APending Publication Date: 2025-04-15AOB MEDICAL CO LTD

Patent Information

Application Number
JP2023171930
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-10-03
Publication Date
2025-04-15

AI Technical Summary

Technical Problem

The current process for importing unapproved drugs into Japan is cumbersome and prone to delays or rejection due to incomplete documentation and complex permission requirements.

Method used

A drug import support device and method that collects necessary information from doctors, constructs comprehensive data for import applications, and submits applications to designated institutions, thereby streamlining the import process and reducing the risk of delays or rejections.

Benefits of technology

The solution significantly reduces the likelihood of import delays or rejections by ensuring complete and accurate documentation, thereby facilitating the import of unapproved drugs into Japan.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2025062725000001_ABST
    Figure 2025062725000001_ABST
Patent Text Reader

Abstract

To provide a medicine import support device, a medicine import support method, and a medicine import support program each of which enables reduction of the possibility that medicine cannot be imported and that import is delayed.SOLUTION: A medicine import support device is provided, receiving an information input from a doctor side in order to collect information necessary for importing medicine, the medicine import support device includes: a first display control portion 12a for displaying an import medicine page and a purchase quantity input page for receiving information of medicine to be imported from abroad; a second display control portion 12b for displaying a detailed page for inputting information of use applications, the purpose of use, and a use quantity regarding the medicine to be imported from abroad; and a data construction portion 13 for constructing data which puts together the medicine information received through the import medicine page and the purchase quantity page, the information of the use applications, the purpose of use, and the use quantity input through the detailed page, and the information of the doctor side.SELECTED DRAWING: Figure 2
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a drug import support device, a drug import support method, and a drug import support program. [Background technology]

[0002] It has been known that pharmaceuticals that have not been approved in Japan tend not to be distributed domestically (see, for example, Patent Document 1). [Prior art documents] [Patent documents]

[0003] [Patent Document 1] JP 2023-120330 A Summary of the Invention [Problem to be solved by the invention]

[0004] Here, when a doctor wants to use a drug that is not distributed domestically on a patient, the doctor imports the drug himself or herself to obtain it. However, importing drugs personally is not easy, and permission must be obtained from the designated agency (the Ministry of Health, Labor and Welfare as of September 2023). If there are any defects in the documents submitted when obtaining permission, the drug may not be able to be imported or there may be a delay in the import.

[0005] The present invention has been made to solve such problems, and its purpose is to provide a pharmaceutical import support device, a pharmaceutical import support method, and a pharmaceutical import support program that make it possible to reduce the possibility of being unable to import pharmaceuticals or of delays in the import. [Means for solving the problem]

[0006] The pharmaceutical import support device of the present invention is a pharmaceutical import support device that accepts information input from a doctor and collects information necessary for importing pharmaceuticals, and is equipped with a first display control means for displaying a first screen for accepting information on pharmaceuticals to be imported from a foreign country, a second display control means for displaying a second screen for accepting information on the intended use, purpose of use, and quantity to be used for the pharmaceuticals to be imported from a foreign country, and a data construction means for constructing data summarizing the pharmaceutical information accepted through the first screen displayed by the first display control means, the intended use, purpose of use, and quantity to be used entered through the second screen displayed by the second display control means, and information from the doctor.

[0007] In addition, the pharmaceutical import support method of the present invention is a pharmaceutical import support method of a pharmaceutical import support device that accepts information input from a doctor and collects information necessary for importing pharmaceuticals, and is characterized by comprising a first display control step of displaying a first screen to accept information on pharmaceuticals to be imported from a foreign country, a second display control step of displaying a second screen for entering information on the intended use, purpose of use, and quantity to be used for the pharmaceuticals to be imported from a foreign country, and a data construction step of constructing data summarizing the pharmaceutical information accepted through the first screen displayed in the first display control step, the information on the intended use, purpose of use, and quantity to be used entered through the second screen displayed in the second display control step, and information from the doctor.

[0008] Furthermore, the pharmaceutical import support program according to the present invention causes a computer to execute the above steps. Effect of the Invention

[0009] According to the present invention, it is possible to provide pharmaceutical import support that can reduce the possibility of pharmaceuticals being unable to be imported or of delays in importing. [Brief description of the drawings]

[0010] [Figure 1]1 is a configuration diagram showing a drug import application system including a drug import support device according to an embodiment of the present invention. [Diagram 2] 2 is a block diagram showing a detailed configuration of a main server shown in FIG. 1. [Diagram 3] 3 is a first conceptual diagram showing a part of the memory contents stored in the memory unit shown in FIG. 2. FIG. [Figure 4] 3 is a second conceptual diagram showing another part of the memory contents stored in the memory unit shown in FIG. 2. FIG. [Diagram 5] FIG. 3 is a diagram showing a display image displayed by the display control unit shown in FIG. 2, showing an initial screen. [Figure 6] 3 is a diagram showing a display image displayed by the display control unit shown in FIG. 2, showing a medical professional page. FIG. [Figure 7] FIG. 3 is a diagram showing a display image displayed by the display control unit shown in FIG. 2, illustrating a login screen. [Figure 8] 3 is a diagram showing a display image displayed by the display control unit shown in FIG. 2, showing an imported medicine page. [Figure 9] FIG. 3 is a diagram showing a display image displayed by the display control unit shown in FIG. 2, showing a purchase quantity input page. [Figure 10] FIG. 3 is a diagram showing a display image displayed by the display control unit shown in FIG. 2, showing a details page. [Figure 11] FIG. 3 is a diagram showing a display image displayed by the display control unit shown in FIG. 2, illustrating a first change in the intended use. [Figure 12] 3 is a diagram showing a display image displayed by the display control unit shown in FIG. 2, illustrating a second change in the intended use. [Figure 13] 13 is a first flowchart showing details of a pharmaceutical import support method by a main server, the first half of which is shown. [Figure 14] 13 is a first flowchart showing details of a pharmaceutical import support method by a main server, the latter half of which is shown. [Figure 15]13 is a second flowchart showing details of the pharmaceutical import support method by the main server. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0011] The present invention will be described below along with preferred embodiments. Note that the present invention is not limited to the embodiments shown below, and can be modified as appropriate within the scope of the present invention. In addition, in the embodiments shown below, some configurations are omitted from illustration and description, but it goes without saying that publicly known or well-known technologies are appropriately applied to the details of the omitted technologies within the scope of the contents described below.

[0012] FIG. 1 is a configuration diagram showing a drug import application system including a drug import support device according to this embodiment. As shown in FIG. 1, the drug import application system 1 is composed of a main server (drug import support device) 10 and multiple doctor terminals 20. The main server 10 operates as a drug import support device when the doctor terminal 20 accesses the main server 10 via an Internet line, and stores a drug import support program. This main server 10 accepts information input from the doctor and collects information required for importing drugs not approved in Japan (hereinafter simply referred to as drugs). The doctor terminal 20 is operated by a doctor or the like, and is capable of purchasing imported drugs by connecting to the main server 10 and performing a predetermined login operation.

[0013] Particularly in this embodiment, the main server 10 has a function of preparing application documents or preparing application data and submitting an import application to the specified organization DA when it accepts a purchase of a medicine from the doctor's terminal 20. The main server 10 may submit an import application to the specified organization DA every time it accepts a purchase from the doctor's terminal 20, but it may also be configured to measure a counting period, such as one month or one week, and when the counting period has elapsed, to count the purchases of medicines accepted during that period and submit an import application all at once.

[0014] Fig. 2 is a block diagram showing a detailed configuration of the main server 10 shown in Fig. 1. As shown in Fig. 2, the main server 10 includes a storage unit (storage means) 11, a display control unit 12, a data construction unit (data construction means) 13, a lower limit value calculation unit (lower limit value calculation means) 14, and a transmission unit (transmission means) 15.

[0015] The storage unit 11 stores information related to drug import applications as well as a program for operating the main server 10 as a drug import support device. Figure 3 is a first conceptual diagram showing a part of the memory contents stored in the storage unit 11 shown in Figure 2.

[0016] As shown in FIG. 3, the storage unit 11 stores drug information D1 indicating a drug that can be purchased by import, intended use information D2 indicating an intended use corresponding to the drug to be purchased, and intended use information D3 indicating an intended use corresponding to the intended use. The intended use is a broad concept of how to use the drug, and the intended use is a subconcept (specific reason for use) of how to use the drug. Regarding import applications, if an intended use that is not suitable for the drug or an intended use that does not match the intended use is written on documents, etc., import permission may not be granted, or a considerable period of time may be required to correct the content to an appropriate one, resulting in a delay in import. In this embodiment, the storage unit 11 stores in advance the drug information D1, intended use information D2, and intended use information D3 that are a combination suitable for import, so that the information is not inappropriate for import.

[0017] The memory unit 11 also stores the contents shown in Fig. 4. Fig. 4 is a second conceptual diagram showing another part of the memory contents stored in the memory unit 11 shown in Fig. 2. As shown in Fig. 4, the main server 10 stores all or part of a large number of data at the time of past import applications (data constructed by the data construction unit 13 described below), and also stores additional information D10 indicating whether or not the import application for each data was permitted.

[0018] In the example shown in FIG. 4, the storage unit 11 stores a part of the data of past import applications. Specifically, the storage unit 11 stores, as part of the data of the import application, the following: applied drug information D4 indicating the applied drug; applied purchase quantity information D5 indicating the purchase quantity of the applied drug; applied use information D6 indicating the intended use of the applied drug; applied purpose information D7 indicating the intended use of the applied drug; applied use quantity information D8 indicating the planned use quantity of the applied drug; and applied period information D9 indicating the planned use period of the applied drug. The storage unit 11 stores such a part of the data of the past import application in association with additional information D10 indicating whether the import application has been approved. The storage unit 11 may store all of the data at the time of the past application, including the purchasing doctor's name, in association with the additional information D10.

[0019] Referring again to Fig. 2, the display control unit 12 controls the display contents displayed on the doctor's terminal 20 when the doctor's terminal 20 accesses the main server 10. Figs. 5 to 12 are diagrams showing display images displayed by the display control unit 12 shown in Fig. 2, with Fig. 5 showing an initial screen, Fig. 6 showing a medical personnel page, Fig. 7 showing a login screen, and Fig. 8 showing an imported medicine page. Also, Fig. 9 shows a purchase quantity input page, Fig. 10 shows a details page, Fig. 11 shows a first example of a change in the intended use, and Fig. 12 shows a second example of a change in the intended use.

[0020] First, when the doctor's terminal 20 accesses the main server 10 by inputting a specific URL, the display control unit 12 of the main server 10 causes the display unit of the doctor's terminal 20 to display the initial screen shown in FIG.

[0021] As shown in Fig. 5, the initial screen has an operation section O1 consisting of multiple items such as "HOME", "PHILOSOPHY", "BUSINESS", "BLOG", "ADVISOR", "PARTER", "COMPANY" and "CONTACT" for providing information other than the import of pharmaceuticals. The initial screen also has an operation section O2 in the upper right corner of the image for transitioning to a medical professional page. The operator of the doctor's terminal 20 can display the medical professional page by specifying and operating the operation section O2.

[0022] As shown in FIG. 6, the medical personnel page (third screen) is a screen whose display is controlled by the third display control unit (third display control means) 12c shown in FIG. 2, and is intended to encourage member registration. The medical personnel page has an input unit I1 for doctor-side information. The medical personnel page also has an upload unit AP for medical license, an input unit I2 for login information, an input unit I3 for consenting to the membership terms and conditions, and an operation unit O3 for transmitting these pieces of information. The operator of the doctor-side terminal 20 can input appropriate content, etc. into the input units I1 to I3, upload an image of the medical license, etc. through the upload unit AP, and then operate the operation unit O3 to transmit the necessary information to the management side of the main server 10. The management side performs an examination through image processing or manual examination, and if there is no problem as a result of the examination, allows login with the email address and password entered into the input unit I2, and notifies the doctor-side terminal 20 of this in a predetermined manner. In particular, in this embodiment, the third display control unit 12c displays the medical personnel page including the upload unit AP that encourages uploading of the medical license. For this reason, if a medical license is not uploaded, the operators of the main server 10 can determine that there is a problem with the screening process in order to prevent fraudulent imports by impersonating a doctor, and can prevent the user from logging in.

[0023] 6 has an operation section O4 for transitioning to a login screen in the upper right corner of the image. The operator of the doctor terminal 20 can display the login screen by specifying the operation section O4.

[0024] As shown in Fig. 7, the login screen has an email address input section I4, a password input section I5, an input section I6 for specifying whether to store the login information entered into these input sections I4 and I5, and an operation section O5 for executing the login. The operator of the doctor's terminal 20 can display the imported medicine page by inputting appropriate information into the input sections I4 and I5 and specifying and operating the operation section O5. Furthermore, the operator of the doctor's terminal 20 can store the information in the input sections I4 and I5 by specifying the input section I6 when operating the operation section O5.

[0025] As shown in Fig. 8, the imported medicine page (first screen) is a screen whose display is controlled by the first display control unit (first display control means) 12a shown in Fig. 2, and is intended to receive information on medicines to be imported from abroad. This imported medicine page displays medicines that can be imported and their prices, and an image portion showing the medicine is used as an operation unit O6 for specifying the medicine. The operator of the doctor's terminal 20 can select the medicine to purchase by specifying one of the medicine images G1 from within the operation unit O6, and can display a purchase quantity input page.

[0026] As shown in Fig. 9, the purchase quantity input page (first screen) is also a screen whose display is controlled by the first display control unit 12a. The purchase quantity input page has an image G2 of the selected medicine, a display section for information D11 such as details of the selected medicine and delivery estimate, an input section I7 for inputting the purchase quantity, and an operation section O7 for indicating the purchase intention. The operator of the doctor's terminal 20 can display the details page by inputting the purchase quantity into the input section I7 and specifying the operation section O7.

[0027] As shown in FIG. 10, the details page (second screen) is a screen that is displayed and controlled by the second display control unit (second display control means) 12b shown in FIG. 2, and is intended to input information such as the use, purpose of use, and amount of use of the drug imported from a foreign country. The details page has an input section I8 for inputting the use of the drug selected on the imported drug page shown in FIG. 8 by selecting it from multiple options, an input section I9 for inputting the purpose of use of the drug by selecting it from multiple options, an input section I10 for specifying the approximate unit of the use period of the drug by selecting it from multiple options, and an input section I11 for inputting the amount of use of the drug. Note that "monthly", "weekly", and "daily" shown in the input section I10 are examples of information on the planned period of use of the drug. The input section I10 may be capable of inputting a clear planned period until completion of use, such as "3 months", "1 month", "15 days", and "5 days".

[0028] The details page also has a display section for lower limit information D12 that indicates the lower limit of the quantity of the pharmaceutical to be used, an input section I12 for expressing the intention to import at the doctor's own responsibility, an input section I13 for expressing the intention to delegate the import to a third party, an operation section O8 for returning to the previous screen shown in Figure 9, and an operation section O9 for sending information entered or selected on the details page and the previous page, etc.

[0029] The operator of the doctor's terminal 20 can display the imported medicine page shown in Fig. 8 or the purchase quantity input page shown in Fig. 9 by specifying the operation unit O8. The operator of the doctor's terminal 20 can also input information to the input units I8 to I13 and request a third party to import medicines by specifying the operation unit O9.

[0030] Here, the second display control unit 12b displays the details page after the first display control unit 12a displays the imported drug page and receives information on the imported drug. This allows the operator of the doctor's terminal 20 to input information on the intended use, purpose, and quantity of the drug after identifying the drug, which makes it easier to prevent input errors compared to the case where the intended use, purpose, and quantity of the drug are input first.

[0031] Furthermore, the second display control unit 12b changes the contents of the intended use in the input unit I9 (at least one of the contents of the options and the number of options) based on the option of the intended use selected in the input unit I8 of the details page. For example, in the example shown in Fig. 10, "nutritional supplementation" is selected for the input unit I8. Therefore, the second display control unit 12b displays the options of "chronic fatigue syndrome" and "improvement of hangover", which are intended uses corresponding to the intended use of "nutritional supplementation", in the intended use input unit I9 based on the information D2 and D3 shown in Fig. 3.

[0032] Also, assume that "beauty" is selected for input section I8 as shown in Fig. 11. In this case, the second display control section 12b displays options of "removal of melanin pigment related to skin blemishes," "skin whitening effect," "anti-aging," "anti-aging," "detoxification effect," and "improvement of menopausal symptoms specific to women," which are intended uses corresponding to the intended use of "beauty," in the intended use input section I9 based on the information D2 and D3 shown in Fig. 3.

[0033] Furthermore, assume that "dental treatment" is selected for input section I8 as shown in Fig. 12. In this case, the second display control section 12b displays options of "cheilitis", "periodontal disease", "stomatitis", "removal of pigmentation after angular cheilitis", "oral mucosal inflammation", "prevention of gingival recession", "promotion of wound treatment after implant surgery", and "improvement of healing power after surgery" which are intended uses corresponding to the intended use of "dental treatment" in the intended use input section I9 based on the information D2 and D3 shown in Fig. 3.

[0034] As described above, in this embodiment, the second display control unit 12b changes at least one of the content and number of options for the intended use based on the selected option for the intended use. This allows only the intended use appropriate for the selected intended use to be selected, thereby reducing the possibility of an erroneous import application.

[0035] Although not shown, in this embodiment, the second display control unit 12b preferably changes at least one of the content of options for intended use and the number of options on the details page based on the information of the drug received through the imported drug page shown in FIG. 8. This is because it is possible to prevent the selection of an intended use that is not suitable for the selected drug, thereby reducing the possibility of an erroneous import application. In this case, the second display control unit 12b changes at least one of the content of options for intended use and the number of options on the details page based on the information D1 and D2 shown in FIG. 3. For example, when formulation B is selected on the imported drug page, the second display control unit 12b allows only "cancer treatment" and "specific disease" corresponding to formulation B to be selected, as shown in FIG. 3.

[0036] Referring again to FIG. 10, the second display control unit 12b changes the contents of the input unit I11 based on the information of the medicine accepted through the imported medicine page shown in FIG. 8 and the information of the planned period for the use of the medicine (the selection of the input unit I10). In detail, the second display control unit 12b changes the first image portion P1 according to the selection of the input unit I10. Here, in the example shown in FIG. 10, "monthly" is selected in the input unit I10. Therefore, the second display control unit 12b changes the first image portion P1 to "monthly". Therefore, when "weekly" or "daily" is selected in the input unit I10, the second display control unit 12b changes the first image portion P1 to "weekly" or "daily". Furthermore, the second display control unit 12b changes the second image portion P2 based on the information of the medicine that has been selected. Here, in the example shown in FIG. 10, a medicine sold in a glass or plastic container is selected. Therefore, the second display control unit 12b changes the second image portion P2 to "vial." Therefore, the second display control unit 12b changes the second image portion P2 to "tablet" or "packet" depending on the selected medicine. The above changes contribute to inputting the appropriate quantity.

[0037] In addition, the second display control unit 12b displays lower limit information D12, which indicates the lower limit of the quantity of the drug to be used, adjacent to the input unit I11 for inputting the quantity of the drug to be used. This lower limit is appropriate for import applications, and is displayed as a percentage of the purchase quantity in FIG. 10. If a quantity below this lower limit is entered in the input unit I11, it is likely that there will be an error in the import application. Therefore, by displaying such lower limit information D12, it is possible to reduce the possibility of an erroneous import application.

[0038] Referring again to FIG. 2, the lower limit of the lower limit information D12 is preferably calculated by the lower limit calculation unit 14. As described with reference to FIG. 4, the storage unit 11 stores all or part of many pieces of data at the time of past import applications, and stores additional information D10 indicating whether the import application was approved for each of them. For this reason, the lower limit calculation unit 14 judges a quantity (indicated as a percentage) that was not approved even once in past import applications to be NG, and judges a quantity (indicated as a percentage) that was 100% approved in past import applications to be OK, and calculates the quantity (indicated as a percentage) that was OK as the lower limit. In addition, the lower limit calculation unit 14 calculates the lower limit according to a certain standard, such as a quantity (indicated as a percentage) that was approved 95% or more in past import applications. This makes it possible to display a more appropriate lower limit that takes into account past trends.

[0039] In addition, the second display control unit 12b displays both an input section I12 for indicating the intention to import under the doctor's responsibility, and an input section I13 for indicating the intention to entrust the import to a third party, within the details page (see FIG. 10). This clarifies the doctor's responsibility and the import agent, and reduces the possibility of defects occurring in the import application.

[0040] Although not described above, the display control unit 12 may include a process of displaying, in addition to the screens shown in Figures 5 to 12, a payment information input screen for inputting information regarding payment, a payment screen for making a payment, etc. Furthermore, within the screens shown in Figures 5 to 12, an operation to go back to the previous screen as appropriate may be possible.

[0041] The data construction unit 13 constructs data that compiles the input contents of each page shown in Figures 8 to 10 and the doctor's information (medical institution name, address, doctor name, etc.). The constructed data may be data that can be sent directly to the specified institution DA for an import application, or image data to be used when submitting a written import application to the specified institution DA. Such data construction unit 13 allows for appropriate import applications to be made.

[0042] Next, a detailed description will be given of the method for supporting drug imports by the main server 10. Figures 13 and 14 are a first flowchart showing details of the method for supporting drug imports by the main server 10. The flowchart shown in Figure 13 is executed when the doctor's terminal 20 accesses the main server 10 by inputting a specific URL, and an initial screen is displayed at the start.

[0043] As shown in Fig. 13, first, the main server 10 judges whether or not a transition operation to the medical personnel page has been performed by operating the operation unit O2 shown in Fig. 5 (S1). If no transition operation to the medical personnel page has been performed (S1: NO), this process is repeated until it is determined that a transition operation has been performed.

[0044] On the other hand, if an operation to transition to the medical personnel page has been performed (S1: YES), the third display control unit 12c displays the medical personnel page shown in Fig. 6 (S2). After that, the main server 10 determines whether or not an operation to transition to the login screen shown in Fig. 7 has been performed by operating the operation unit O4 shown in Fig. 6 (S3).

[0045] If there is no operation to transition to the login screen (S3: NO), the main server 10 judges whether or not the necessary information has been input through the input units I1 to I3 and the upload unit AP, and whether or not a transmission operation has been performed through the operation unit O3 (S4). If the necessary information has been input and a transmission operation has been performed (S4: YES), the main server 10 executes a process (transmission process) of accepting the input contents of the input units I1 to I3 and the upload contents through the upload unit AP (S5). Thereafter, the process shown in Figs. 13 and 14 ends. That is, the system is in a state of waiting for examination by the management side of the main server 10. On the other hand, if there has been a transmission operation but the necessary information has not been input, or if the transmission operation has not been performed (S4: NO), the process proceeds to step S3.

[0046] If an operation to transition to the login screen has been performed (S3: YES), the display control unit 12 displays the login screen shown in Fig. 7 (S6). After that, the main server 10 judges whether or not a login operation has been performed by inputting necessary information into the input units I4 and I5 shown in Fig. 7 and operating the operation unit O5 (S7). If no login operation has been performed (S7: NO), this process is repeated until it is determined that a login operation has been performed.

[0047] On the other hand, if a login operation has been performed (S7: YES), the first display control unit 12a displays the imported medicine page shown in Fig. 8 (S8). Next, the main server 10 determines whether or not a medicine selection operation has been performed by selecting one of the medicine images G1 in the operation unit O6 shown in Fig. 8 (S9). If no medicine selection operation has been performed (S9: NO), this process is repeated until it is determined that a medicine selection operation has been performed.

[0048] If a drug selection operation has been performed (S9: YES), the first display control unit 12a displays a purchase quantity input page shown in Fig. 9 (S10). Next, the main server 10 determines whether or not a purchase operation has been performed by inputting a quantity into the input unit I6 shown in Fig. 9 and operating the operation unit O7 (S11). If no purchase operation has been performed (S11: NO), this process is repeated until it is determined that a purchase operation has been performed.

[0049] If a purchase operation has been performed (S11: YES), the second display control unit 12b displays the details page shown in Fig. 10 (S12). At this time, the second display control unit 12b changes the display content of the input unit I8 related to the intended use according to the drug selected by the drug selection operation in step S9. Prior to displaying the details page shown in Fig. 10, the lower limit calculation unit 14 calculates the lower limit, and the second display control unit 12b displays the lower limit calculated by the lower limit calculation unit 14 as lower limit information D12.

[0050] After that, the main server 10 judges whether any one of the usage options shown in the input section I8 has been selected (FIG. 14: S13). If no usage option has been selected (S13: NO), this process is repeated until a usage option is selected.

[0051] When an option for the intended use is selected (S13: YES), the second display control unit 12b changes the display content related to the intended use of the input unit I9 according to the selected option for the intended use (S14). After that, the necessary items are input to the input units I9 to I13, and it is determined whether or not a transmission operation has been performed by the operation unit O9 (S15). If a transmission operation has been performed but the necessary items have not been input, or if a transmission operation has not been performed (S15: NO), the process proceeds to step S13.

[0052] On the other hand, if the necessary items have been input and a transmission operation has been performed (S15: YES), the main server 10 executes a process (transmission process) for accepting the input contents of the input units I8 to I13 (S16) and stores them in the memory unit 11. At this time, the main server 10 also accepts the input contents in Fig. 8 and Fig. 9 and stores them in the memory unit 11. Thereafter, the process shown in Fig. 13 and Fig. 14 ends.

[0053] Fig. 15 is a second flowchart showing details of the pharmaceutical import support method by the main server 10. As shown in Fig. 15, the main server 10 first judges whether the counting period has arrived (S21). If the counting period has not arrived (S21: NO), this process is repeated until it is judged that the counting period has arrived.

[0054] On the other hand, if the counting period has arrived (S21: YES), the main server 10 reads the information stored in step S16 shown in FIG. 14 during the counting period and performs counting, for example, for each imported drug (S22). Then, the data construction unit 13 of the main server 10 creates application documents or creates application data based on the collected data (S23). Next, the main server 10 prints the application documents, or the transmission unit 15 performs transmission processing of the application data (S24). The destination of the application documents or application data is a specified institution DA. Thereafter, the process shown in FIG. 15 ends.

[0055] In this way, according to the pharmaceutical import support device and pharmaceutical import support method of the present embodiment, in addition to pharmaceutical information, information on the use, purpose of use, and amount used, which are prone to deficiencies during import, is input, and data that compiles this information with information from the doctor is constructed. Therefore, by submitting an import application based on the constructed data, the possibility of document deficiencies can be reduced. Therefore, it is possible to provide a pharmaceutical import support device that makes it possible to reduce the possibility of import failure or delays.

[0056] In addition, since the details page is displayed after the information on the imported medicines page is received, the information on the intended use, purpose, and quantity is input after the medicine is decided. This makes it easier to prevent input errors compared to when the information on the intended use, purpose, and quantity is input first, and makes it possible to provide a medicine import support device that can further reduce the possibility of import failure or delays.

[0057] In addition, at least one of the options for intended use and the number of options on the details page is changed based on the information on the drug received through the imported drug page. This allows only appropriate intended uses for the received drug to be selected, making it possible to provide a drug import support device that can further reduce the possibility of import failure or delays.

[0058] In addition, at least one of the options for intended use and the number of options is changed based on the selected option for intended use. This makes it possible to provide a pharmaceutical import support device that allows only intended uses appropriate for the selected intended use to be selected, further reducing the possibility of import failure or delay in import.

[0059] In addition, the content of the input screen for the quantity used (image parts P1 and P2 of input section I11) is changed based on the information on the medicine received through the imported medicine page and the input content of input section I10. This contributes to inputting the appropriate quantity, and it is possible to provide a medicine import support device that can further reduce the possibility of import failure or delays in importing.

[0060] In addition, the minimum value that should be entered for the quantity of the drug to be used is displayed, which reduces the possibility of errors occurring due to entering a quantity below the minimum value, and makes it possible to provide a drug import support device that can further reduce the possibility of import failure or delays.

[0061] In addition, the lower limit is calculated and displayed based on data on past import approvals, making it possible to provide a pharmaceutical import support device that can display a more appropriate lower limit and further reduce the possibility of import refusal or delays.

[0062] In addition, items are displayed for inputting whether the import will be done under the doctor's responsibility or whether the import will be entrusted to a third party. This makes it clear that the import will be done under the doctor's responsibility, and the import itself can be entrusted to a third party. This makes it possible to provide a pharmaceutical import support device that can reduce the possibility of import failure or delays while also reducing the hassle involved with importing.

[0063] The system further includes a transmission unit 15 that transmits the constructed data to a prescribed authority DA that permits the import of pharmaceuticals. This makes it possible to submit an import application using the data as is, reducing the possibility of import failure or delay, while also reducing the labor required for importation.

[0064] In addition, by requiring doctors to upload their medical licenses, it is possible to prevent impersonation by non-doctors and contribute to preventing the illegal import of medicines.

[0065] Furthermore, according to the drug import support program of this embodiment, the above-mentioned drug import support device and method can be realized.

[0066] The present invention has been described above based on an embodiment, but the present invention is not limited to the above embodiment, and modifications may be made without departing from the spirit of the present invention, and other technologies may be appropriately combined to the extent possible.

[0067] For example, in the above embodiment, the display of the doctor's terminal 20 is controlled by the main server 10, but this is not particularly limited, and the drug import support program may be downloaded to the doctor's terminal 20, and the doctor's terminal 20 itself may control the display. Also, the drug import support device may be constructed by cooperation of three or more devices.

[0068] In addition, in the above, the second display control unit 12b changes the contents of the input unit I11 based on both the information on the medicine received through the imported medicine page shown in Fig. 8 and the information on the planned period for using the medicine (the selection in the input unit I10). However, this is not limited to this, and the contents of the input unit I11 may be changed based on either one of them. [Explanation of symbols]

[0069] 1: Drug import application system 10: Main server (medicine import support device) 11: Storage unit (storage means) 12: Display control section 12a: First display control unit (first display control means) 12b: Second display control unit (second display control means) 12c: Third display control unit (third display control means) 13: Data construction section (data construction means) 14: Lower limit calculation unit (lower limit calculation means) 15: Transmission unit (transmission means) 20: Doctor's terminal AP: Upload section D1: Drug Information D2: Usage information D3: Purpose of use information D4: Drug application information D5: Purchase quantity information D6:Application usage information D7:Application purpose information D8: Application usage quantity information D9:Application period information D10: Additional information D12: Lower limit information DA: Designated agency I1~I13: Input section O1~O9:Operation unit

Claims

1. A drug import support device that accepts information input from a doctor and collects information required for importing drugs, a first display control means for displaying a first screen for receiving information on medicines to be imported from abroad; a second display control means for displaying a second screen for inputting information on the use, purpose, and quantity of the drug to be imported from a foreign country; a data construction means for constructing data summarizing information on the medicine received through the first screen displayed by the first display control means, information on the use, purpose, and amount of use input through the second screen displayed by the second display control means, and information on the doctor's side; A pharmaceutical import support device comprising:

2. The second display control means displays the second screen after the first screen is displayed by the first display control means and information on the medicine to be imported is received.

2. The pharmaceutical import support device according to claim 1 .

3. The second display control means displays the second screen for inputting the intended use by selecting from a plurality of options for the intended use, and changes at least one of the content and number of options for the intended use on the second screen based on the information of the drug accepted through the first screen displayed by the first display control means.

3. The pharmaceutical import support device according to claim 2.

4. The second display control means displays the second screen for inputting the purpose of use by allowing the user to select from a plurality of options for the purpose of use, and changes at least one of the content and number of options for the purpose of use based on the selected option for the purpose of use.

4. The pharmaceutical import support device according to claim 3.

5. The second display control means changes the content of an input portion screen for inputting a quantity to be used on the second screen based on at least one of the information on the medicine received through the first screen and information on a planned period for using the medicine.

3. The pharmaceutical import support device according to claim 2.

6. The second display control means displays a lower limit value of a value to be input for the quantity of the drug accepted through the first screen.

3. The pharmaceutical import support device according to claim 2.

7. a storage means for storing a large number of data items previously constructed by said data construction means or parts of said data items, and for storing additional information indicating whether or not each of said data items has been permitted to be imported; and a lower limit calculation means for calculating a lower limit based on the quantity of use input in the data on the past import permission for the medicine accepted through the first screen, The second display control means displays the lower limit value calculated by the lower limit value calculation means as the lower limit value of the value to be input.

7. The pharmaceutical import support device according to claim 6.

8. The second display control means further displays, on the second screen, an input section for inputting that the import is to be performed under the doctor's responsibility and that the import is to be entrusted to a third party.

3. The pharmaceutical import support device according to claim 2.

9. The data construction means further includes a transmission means for transmitting the data constructed by the data construction means to a predetermined organization that permits the import of pharmaceuticals.

2. The pharmaceutical import support device according to claim 1 .

10. 3. The pharmaceutical import support device according to claim 2, further comprising a third display control means for displaying a third screen for uploading a medical license.

11. A drug import support method for a drug import support device that receives information input from a doctor and collects information required for importing drugs, a first display control step of displaying a first screen for receiving information on medicines to be imported from abroad; a second display control step of displaying a second screen for inputting information on the use, purpose, and quantity of the drug to be imported from a foreign country; a data construction step of constructing data summarizing information on the medicine received through the first screen displayed in the first display control step, information on the intended use, purpose of use, and amount of use input through the second screen displayed in the second display control step, and information on the doctor's side; A drug import support method of a drug import support device comprising:

12. A drug import support program for causing a computer to execute the drug import support method according to claim 11.

Citation Information

Patent Citations

  • Information provision system

    JP2023120330A

Cited By

  • Support device, support method, and program

    JP7918613B1